Literature DB >> 15215131

Purification and characterization of recombinant Staphylococcus haemolyticus DNA gyrase and topoisomerase IV expressed in Escherichia coli.

Joel C Bronstein1, Stacey L Olson, Kristin LeVier, Mark Tomilo, Peter C Weber.   

Abstract

The subunits of DNA gyrase and topoisomerase IV from Staphylococcus haemolyticus were expressed in Escherichia coli, purified to homogeneity, and used to reconstitute active enzymes that were sensitive to known topoisomerase inhibitors. This represents the first description of a method for isolating type II topoisomerases of a coagulase-negative staphylococcal species.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15215131      PMCID： PMC434177          DOI： 10.1128/AAC.48.7.2708-2711.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  23 in total

Review 1.  Coagulase-negative staphylococci as a cause of infections related to intravascular prosthetic devices: limitations of present therapy.

Authors:  T Schulin; A Voss
Journal:  Clin Microbiol Infect       Date:  2001       Impact factor: 8.067

Review 2.  Coagulase-negative staphylococci: pathogens with increasing clinical significance.

Authors:  C C Patrick
Journal:  J Pediatr       Date:  1990-04       Impact factor: 4.406

3.  Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection.

Authors:  L A Veach; M A Pfaller; M Barrett; F P Koontz; R P Wenzel
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

4.  Clinical and microbiologic aspects of Staphylococcus haemolyticus infections.

Authors:  D W Isaac; T A Pearson; C A Hurwitz; C C Patrick
Journal:  Pediatr Infect Dis J       Date:  1993-12       Impact factor: 2.129

5.  Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.

Authors:  T D Gootz; R P Zaniewski; S L Haskell; F S Kaczmarek; A E Maurice
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

Review 6.  Antibiotic resistance in staphylococci.

Authors:  D M Livermore
Journal:  Int J Antimicrob Agents       Date:  2000-11       Impact factor: 5.283

7.  Inhibition by quinolones of DNA gyrase from Staphylococcus aureus.

Authors:  M Tanaka; K Sato; Y Kimura; I Hayakawa; Y Osada; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

8.  Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus.

Authors:  J W Froggatt; J L Johnston; D W Galetto; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

9.  Phenotypic and genotypic characterisation of blood isolates of coagulase-negative staphylococci in the newborn.

Authors:  Maria Björkqvist; Bo Söderquist; Eva Törnqvist; Lennart Sjöberg; Hans Fredlund; Inger Kühn; Patricia Colque-Navarro; Jens Schollin
Journal:  APMIS       Date:  2002-04       Impact factor: 3.205

Review 10.  Update on clinical significance of coagulase-negative staphylococci.

Authors:  W E Kloos; T L Bannerman
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.